Differential effects and changes of ceruloplasmin in the hippocampal CA1 region between adult and aged gerbils after transient cerebral ischemia

Neuroscience Research

Volumn 55, Issue 2, 2006, Pages 134-141

  Yoo, Ki Yeon ^a   Hwang, In Koo ^a   Eum, Won Sik ^b   Kim, Dae Won ^b   Kwon, Young Guen ^c   Kang, Tae Cheon ^a   Choi, Soo Young ^b   Kim, Yong Sun ^a   Won, Moo Ho ^a  

^a Hallym University   (South Korea)

^b Division of Life Sciences   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Aging; Antioxidants; Astrocytes; Ceruloplasmin; Hippocampal CA1 pyramidal cells; Neuroprotection; Transient ischemia

Indexed keywords

CERULOPLASMIN; CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROPROTECTIVE AGENT;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CONTROLLED STUDY; FOREBRAIN; GERBIL; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION; TISSUE LEVEL; TRANSIENT ISCHEMIC ATTACK; AGE; ANIMAL; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PYRAMIDAL NERVE CELL; WESTERN BLOTTING;

AGE FACTORS; AGING; ANIMALS; ANTIGENS, CD11B; ASTROCYTES; BLOTTING, WESTERN; CERULOPLASMIN; GENE EXPRESSION REGULATION; GERBILLINAE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; PYRAMIDAL CELLS;

EID: 33746745487     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.02.009     Document Type: Article

References (42)

1. Aouffen M., Paquin J., De Grandpre E., Nadeau R., and Mateescu M.A. Deglycosylated ceruloplasmin maintains its enzymatic, antioxidant, cardioprotective, and neuronoprotective properties. Biochem. Cell Biol. 79 (2001) 489-497
2. Bannister J.V., Bannister W.H., Hill H.A.O., Mahood J.F., Wilson R.L., and Wolfden B.S. Does ceruloplasmin dismute superoxide? No. FEBS Lett. 118 (1980) 127-129
3. Blokhina O., Virolainen E., and Fagerstedt K.V. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann. Bot. (London) 91 (2003) 179-194
4. Calabrese L., and Carbonaro M. An e.p.r. study of the non-equivalence of the copper sites of caeruloplsmin. Biochem. J. 238 (1986) 291-295
5. Candelario-Jalil E., Alvarez D., Merino N., and Leon O.S. Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils. Neurosci. Res. 47 (2003) 245-253
6. Candelario-Jalil E., Mhadu N.H., Al-Dalain S.M., Martinez G., and Leon O.S. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res. 41 (2001) 233-241
7. Celsi F., Ferri A., Casciati A., D'Ambrosi N., Rotilio G., Costa A., Volonte C., and Carri M.T. Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators. Neurochem. Int. 44 (2004) 25-33
8. Chahine R., Mateescu M.A., Roger S., Yamaguchi N., de Champlain J., and Nadeau R. Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart. Can. J. Physiol. Pharmacol. 69 (1991) 1459-1464
9. Chen L., Dentchev T., Wong R., Hahn P., Wen R., Bennett J., and Dunaief J.L. Increased expression of ceruloplasmin in the retina following photic injury. Mol. Vis. 9 (2003) 151-158
10. Connor J.R., Tucker P., Johnson M., and Snyder B. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci. Lett. 159 (1993) 88-90
11. Dore S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., Hurn P.D., Traystman R.J., and Andreasson K. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 54 (2003) 155-162
12. Evans P.H. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49 (1993) 577-587
13. Fujimoto S., Katsuki H., Kume T., Kaneko S., and Akaike A. Mechanisms of oxygen glucose deprivation-induced glutamate release from cerebrocortical slice cultures. Neurosci. Res. 50 (2004) 179-187
14. Goldstein I.M., Kaplan H.B., Edelson H.S., and Weissmann G. Ceruloplasmin. A scavenger of superoxide anion radicals. J. Biol. Chem. 254 (1979) 4040-4045
15. Hwang I.K., Yoo K.Y., Park S.K., An S.J., Lee J.Y., Choi S.Y., Kang J.H., Kwon Y.G., Kang T.C., and Won M.H. Expression and changes of endogenous insulin-like growth factor-1 in neurons and glia in the gerbil hippocampus and dentate gyrus after ischemic insult. Neurochem. Int. 45 (2004) 149-156
16. Hwang I.K., Yoon D.K., Yoo K.Y., Eum W.S., Bahn J.H., Kim D.W., Kang J.H., Kwon H.Y., Kang T.C., Choi S.Y., and Won M.H. Ischemia-related change of ceruloplasmin immunoreactivity in neurons and astrocytes in the gerbil hippocampus and dentate gyrus. Neurochem. Int. 44 (2004) 601-617
17. Ilzecka J. The protective role of ceruloplasmin against the activity of free radicals in brain ischaemia. Ann. Univ. Mariae Curie Sklodowska 51 (1996) 97-101
18. Kil H.Y., Zhang J., and Piantadosi C.A. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J. Cereb. Blood Flow Metab. 16 (1996) 100-106
19. Kindy M.S., Bhat A.N., and Bhat N.R. Transient ischemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus. Mol. Brain Res. 13 (1992) 199-206
20. Kitagawa K., Matsumoto M., Oda T., Niinobe M., Hata R., Handa N., Fukunaga R., Isaka Y., Kimura K., and Maeda H. Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death. Neuroscience 35 (1990) 551-558
21. Li P.A., Liu G.J., He Q.P., Floyd R.A., and Siesjo B.K. Production of hydroxyl free radical by brain tissues in hyperglycemic rats subjected to transient forebrain ischemia. Free Radic. Biol. Med. 27 (1999) 1033-1040
22. Liochev S.L. The role of iron-sulfur clusters in in vivo hydroxyl radical production. Free Radic. Res. 25 (1996) 369-384
23. Liu J., Atamna H., Kuratsune H., and Ames B.N. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann. N.Y. Acad. Sci. 959 (2002) 133-166
24. Loeffler D.A., LeWitt P.A., Juneau P.L., Sima A.A., Nguyen H.U., DeMaggio A.J., Brickman C.M., Brewer G.J., Dick R.D., Troyer M.D., and Kanaley L. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 738 (1996) 265-274
25. Manjula S., Aroor A.R., Raja A., Rao S.N., and Rao A. Elevation of serum ceruloplasmin levels in brain tumours. Acta Neurol. Scand. 86 (1992) 156-158
26. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 20 (1998) 53-57
27. McKenzie D., Bartz J., Mirwald J., Olander D., Marsh R., and Aiken J. Reversibility of Scrapie inactivation is enhanced by copper. J. Biol. Chem. 273 (1998) 25545-25547
28. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., and Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 271 (1996) 1406-1409
29. Oliver C.N., Ahn B.W., Moerman E.J., Goldstein S., and Stadtman E.R. Age-related changes in oxidized proteins. J. Biol. Chem. 262 (1987) 5488-5491
30. Osaki S., Johnson D.A., and Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241 (1966) 2746-2751
31. Patel B.N.C., and David S. Expression of ceruloplasmin by astrocytes and its modulation by cytokines. Proc. Soc. Neurosci. 21 (1995) 564
32. Perry G., Sayre L.M., Atwood C.S., Castellani R.J., Cash A.D., Rottkamp C.A., and Smith M.A. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16 (2002) 339-352
33. Perry G., Taddeo M.A., Petersen R.B., Castellani R.J., Harris P.L., Siedlak S.L., Cash A.D., Liu Q., Nunomura A., Atwood C.S., and Smith M.A. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 16 (2003) 77-81
34. Rami A., Jansen S., Giesser I., and Winckler J. Post-ischemic activation of caspase-3 in the rat hippocampus: evidence of an axonal and dendritic localisation. Neurochem. Int. 43 (2003) 211-223
35. Seitz R.J., and Wechsler W. Immunohistochemical demonstration of serum proteins in human cerebral gliomas. Acta Neuropathol. 73 (1987) 145-152
36. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., and Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10540-10543
37. Springer J.E., Azbill R.D., Mark R.J., Begley J.G., Waeg G., and Mattson M.P. 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68 (1997) 2469-2476
38. In: Thiessen D., and Yahr P. (Eds). The Gerbil in Behavioral Investigations. Mechanisms of Territoriality and Olfactory Communication (1977), University of Texas Press, Austin
39. Tian H., Zhang Q., Li H., and Zhang G. Antioxidant N-acetylcysteine and AMPA/KA receptor antagonist DNQX inhibited mixed lineage kinase-3 activation following cerebral ischemia in rat hippocampus. Neurosci. Res. 47 (2003) 47-53
40. Won M.H., Kang T.C., Jeon G.S., Lee J.C., Kim D.Y., Choi E.M., Lee K.H., Choi C.D., Chung M.H., and Cho S.S. Immunohistochemical detection of oxidative DNA damage induced by ischemia-reperfusion insults in gerbil hippocampus in vivo. Brain Res. 836 (1999) 70-78
41. Yoshida K., Kaneko K., Miyajima H., Tokuda T., Nakamura A., Kato M., and Ikeda S. Increased lipid peroxidation in the brains of aceruloplasminemia patients. J. Neurol. Sci. 175 (2000) 91-95
42. Zhou A.M., Li W.B., Li Q.J., Liu H.Q., Feng R.F., and Zhao H.G. A short cerebral ischemic preconditioning up-regulates adenosine receptors in the hippocampal CA1 region of rats. Neurosci. Res. 48 (2004) 397-404